Theralase Technologies Inc (TLTFF)

[Onthegogo]

Dr. Rueck: Where do PDCs best exert their deadly effect?
Now that we had amazing results with a non-optimized brain cancer (GBM) experiment where agressive tumor disappeared from the MRI at one point in time (only to re-grew at half the pace), we now know this Dr. Rueck report is extremely positive and that it will be published in synched and in support with positive NMIBC human data in due time.

This is why this 2nd cancer indication data (GBM) was so important to have. It now confirms that our PDC is potent in more than one type of cancers. And it happens that it is amazingly potent against 2 hard-to-beat cancers. Not on 2 superficial type of cancers.

Read more at http://www.stockhouse.com/companies/bullboard?symbol=v.tlt&postid=25855477#rj3tted4G5QlgR59.99